Achieving patient centricity: 4 key lessons from orphan disease companies
Orphan drugs – leading the way in patient centricity
The need to increase patient centricity in pharma is currently a hot topic in the industry, but in the orphan drug / rare disease space it has been a reality for many years.
Read the latest article from Executive Insight and learn the 4 key lessons that are crucial for true patient engagement!
